Advertisement

Journal of Neuro-Oncology

, Volume 6, Issue 4, pp 355–359 | Cite as

Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities

  • Frank Adams
  • Francisco Fernandez
  • Giora Mavligit
Article

Summary

Eleven patients ranging in age from 52 to 80 years, undergoing treatment for cancer with various preparations of interferon received neurobehavioral evaluations after experiencing unexpectedly severe organic mental disorders. The reactions ranged from delirium to extrapyramidal symptoms, mania, and neurasthenia with catatonic episodes. Computed tomographic (CT) scans of the brain disclosed unsuspected pre-existing neurologic abnormalities in all patients, including cerebral atrophy (6/11), brain metastases (4/11), and evidence of head injury incurred 40 years earlier (l/11). These findings suggest that cancer patients with pre-existing neurologic dysfunctions are at increased risk for severe interferon neurotoxicity.

Key words

interferon neurotoxicity CNS abnormalities pre-existing 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adams F, Quesada JR, Gutterman JU: Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 252:938–941, 1984Google Scholar
  2. 2.
    Quesada JR, Hawkins M, Horning S, Alexanian R, Borden E, Merigan T, Adams F, Gutterman JU: A collaborative phase I–II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma and multiple meyloma. The American Journal of Medicine 77:427–432, 1984Google Scholar
  3. 3.
    Rohatiner AZS, Prior PF, Burton AC, Smith AT, Balkwill FR, Lister TA: Central nervous system toxicity of interferon. Br J Cancr 47:419–422, 1983Google Scholar
  4. 4.
    Mattson K, Niiranen A, Iiavanainen M, Farkkila M, Bergstrom L, HolstiLR: Neurotoxicity of interferon. Cancer Treatment Reports 67:958–961, 1983Google Scholar
  5. 5.
    Suter CC, Westmoreland BF, Sharbrough FW Hermann RB: Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report. Mayo Clin Proc 59:847–850, 1984Google Scholar
  6. 6.
    Adams F, Larson D, Goepfert H: Does the diagnosis of depression in head and neck cancer mask organic brain disease? Otolaryngology Head and Neck Surgery 93:618–624, 1984Google Scholar
  7. 7.
    Obbens EAMT, Feun LG, Leavens ME, Savaraj N, Stewart DJ, Gutterman JU: Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies. Journal of Neuro-Oncology 3:61–67, 1985Google Scholar
  8. 8.
    Bernsen PLJA, Wong-Chung RE, Janssen JThP: Neuralgic amyotrophy and polyradiculopathy during interferon therapy. Lancet 1:50, 1985Google Scholar
  9. 9.
    Adams R, Victor M: Abnormalities of movement and posture due to disease of the extrapyramidal motor system. In: Principles of Neurology. Chapter 3. New York: McGraw-Hill, 1977, pp. 40–61Google Scholar
  10. 10.
    Cummings JL, Benson DF: Subcortical dementias in the extrapyramidal disorders. In: Dementia a clinical approach. Chapter 4. Stoneham: Butterworth Publishers, 1983, pp. 73–124Google Scholar
  11. 11.
    Rosvold HE: The frontal lobe system: cortical-subcortical interrelationships. Acta Neurobiol Exp 32:439–460, 1972Google Scholar
  12. 12.
    Iiavanainen M, Laaksonen R, Niemi M-L, Farkkila M, Bergstrom L, Mattson K, Niiranen A, Cantell K: Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis. Acta Neurol Scand 72:475–480, 1985Google Scholar
  13. 13.
    Fent K, Zbinden G: Toxicity of interferon and interleukin. TIPS 8:100–105, 1987Google Scholar
  14. 14.
    Blalock JE, Smith EM: Human leukocyte interferon: potent endorphin-like opioid activity. Biochem Biophys Res Commun 101:472–478, 1981Google Scholar
  15. 15.
    Cantell K, Pulkkinen E, Elosuo R, Suominen J: Effect of interferon on severe psychiatric diseases. Annals of Clinical Research 12:131–132, 1980Google Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Frank Adams
    • 1
  • Francisco Fernandez
    • 1
  • Giora Mavligit
    • 2
  1. 1.Division of Medicine, The University of TexasM. D. Anderson Hospital and Tumor InstituteHoustonUSA
  2. 2.Department of Clinical Immunology and Biological Therapy, The University of TexasM. D. Anderson Hospital and Tumor InstituteHoustonUSA

Personalised recommendations